Local antibiotic delivery systems in diabetic foot osteomyelitis: Time for one step beyond?

International Journal of Lower Extremity Wounds

Volumn 14, Issue 1, 2015, Pages 87-91

  Panagopoulos, Periklis ^a   Drosos, Georgios ^a   Maltezos, Efstratios ^a   Papanas, Nikolaos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

antibiotics; delivery systems; diabetes mellitus; diabetic foot; infections; osteomyelitis; treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; BONE RESECTION; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC FOOT OSTEOMYELITIS; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMBASE; FOOT CARE; HOSPITAL ADMISSION; HUMAN; MANAGED CARE; MEDLINE; OSTEOMYELITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TIME TO TREATMENT; TREATMENT DURATION; WOUND HEALING; COMPLICATION; DEBRIDEMENT; PROCEDURES;

ANTI-BACTERIAL AGENTS; DEBRIDEMENT; DIABETIC FOOT; DRUG DELIVERY SYSTEMS; HUMANS; OSTEOMYELITIS;

EID: 84927548375     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734614566937     Document Type: Review

References (41)

1. Caric PJ, Dickerson LM, Sack JL.. Diagnosis and management of osteomyelitis. Am Fam Phys. 2001 ; 63: 2413-2420
2. Aragón-Sánchez J.. Treatment of diabetic foot osteomyelitis: a surgical critique. Int J Low Extrem Wounds. 2010 ; 9: 37-59
3. Aragón-Sánchez J.. Seminar review: a review of the basis of surgical treatment of diabetic foot infections. Int J Low Extrem Wounds ; 2011 ; 2011. 33.
4. Aragón-Sánchez J, Lipsky BA, Lázaro-Martínez JL.. Gram-negative diabetic foot osteomyelitis: risk factors and clinical presentation. Int J Low Extrem Wounds. 2013 ; 12: 63-68
5. Edmonds M.. Modern treatment of infection and ischaemia to reduce major amputation in the diabetic foot. Curr Pharm Des. 2013 ; 19: 5008-5015
6. Demetriou M, Papanas N, Panopoulou M, Papatheodorou K, Bounovas A, Maltezos E.. Tissue and swab culture in diabetic foot infections: neuropathic versus neuroischemic ulcers. Int J Low Extrem Wounds. 2013 ; 12: 87-93
7. Papanas N, Maltezos E.. The diabetic foot: established and emerging treatments. Acta Clin Belg. 2007 ; 62: 230-238
8. Papanas N, Mani R.. Advances in infections and wound healing for the diabetic foot: the die is cast. Int J Low Extrem Wounds. 2013 ; 12: 83-86
9. Georgakarakos E, Charalampidis D, Kakagia D, Georgiadis GS, Lazarides MK, Papanas N.. Current achievements with topical negative pressure to improve wound healing in dehiscent ischemic stumps of diabetic patients: a case series. Int J Low Extrem Wounds. 2013 ; 12: 138-145
10. Shone A, Burnside J, Chipchase S, Game F, Jeffcoate W.. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care. 2006 ; 29: 945
11. Game FL.. Osteomyelitis in the diabetic foot: diagnosis and management. Med Clin North Am. 2013 ; 97: 947-956
12. Papanas N, Zissimopoulos A, Maltezos E.. The role of nuclear medicine in the diagnosis of common and specific diabetic infections. Hell J Nucl Med. 2010 ; 13: 150-157
13. Byren I, Peters EJ, Hoey C, Berendt A, Lipsky BA.. Pharmacotherapy of diabetic foot osteomyelitis. Expert Opin Pharmacother. 2009 ; 10: 3033-3047
14. Kessler L, Piemont Y, Ortega F, et al. Comparison of microbiological results of needle puncture vs. superficial swab in infected diabetic foot ulcer with osteomyelitis. Diabet Med. 2006 ; 23: 99-102
15. Game FL, Jeffcoate WJ.. Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia. 2008 ; 51: 962-967
16. Game F.. The advantages and disadvantages of non-surgical management of the diabetic foot. Diabetes Metab Res Rev. 2008 ; 24: S72 - S75
17. Lázaro-Martínez JL, Aragón-Sánchez J, García-Morales E.. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes Care. 2014 ; 37: 789-795
18. Michail M, Jude E, Liaskos C, et al. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds. 2013 ; 12: 94-99
19. Yamashita Y, Uchida A, Yamakawa T, et al. Treatment of osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int Orthop. 1998 ; 22: 247-251
20. Bucholz HW, Engelbrecht H.. Depot effect of various antibiotics mixed with Palacos resins. Chirurg. 1970 ; 40: 511-515
21. Seligson D, Klemm K.. Antibiotic bone cement combinations. Orthop Infect. 1989 ;: 385-417
22. Klem K.. The use of antibiotic-containing bed-chains in the treatment of chronic bone infections. Clin Microbiol Infect. 2001 ; 7: 28-31
23. Nelson CL, McLaren SG, Skinner RA, et al. The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulphate tobramycin pellets. J Orthop Res. 2002 ; 20: 643-647
24. Tentolouris N, Petrikkos G, Vallianou N, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. 2006 ; 12: 186-189
25. Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ.. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs. 2010 ; 70: 1785-1797
26. Panagopoulos P, Tsaganos T, Plachouras D, et al. In vitro elusion of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan™). Int J Antimicrob Agents. 2008 ; 32: 485-487
27. Kanellakopoulou K, Giamarellos-Bourboulis EJ.. Carrier systems for the local delivery of antibiotics in bone infection. Drugs. 2000 ; 59: 1223-1232
28. Kanellakopoulou K, Panagopoulos P, Giannitsioti E, et al. In vitro elution of daptomycin by a synthetic crystallic semihydrate form of calcium sulphate. Stimulan Ant Agents Chemother. 2009 ;: 3106-3107
29. Foster A.. Changes in the care of the diabetic foot: part two. Pract Diabetes Intern. 2001 ; 18: 165-169
30. Armstrong DG, Lipsk BA.. Advances in the treatment of diabetic foot infections. Diabetes Technol Ther. 2004 ; 6: 167-177
31. Lipsky BA, Peters EJ, Berendt AR, et al. International Working Group on Diabetic Foot. Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev. 2012 ; 28: 234-235
32. Lipsky BA, Peters EJ, Senneville E, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012 ; 28: 163-178
33. Salgami EV, Bowling FL, Whitehouse RW, et al. Use of tobramycin-impregnated calcium sulphate pellets in addition to oral antibiotics. Diabetes Care. 2007 ; 30: 181-182
34. Armstrong DG, Findlow AH, Oyibo SO, et al. The use of absordable antibiotic-impregnated calcium sulphate pellets in the management of diabetic foot infections. Diabetic Med. 2001 ; 18: 942-943
35. Sagray BA, Malthotra S, Steinberg JS.. Current therapies for diabetic foot infections and osteomyelitis. Clin Podiatr Med Surg. 2014 ; 31: 58-70
36. Roeder B, Van Gils CC, Mailing S.. Antibiotic beads in the treatment of diabetic pedal osteomyelitis. J Foot Ankle Surg. 2000 ; 39: 124-130
37. Karr JC.. Management in the wound-care center outpatient setting of a diabetic patient with forefoot osteomyelitis using Cerament Bone Void Filler impregnated with vancomycin: off label use. J Am Podiatr Med Assoc. 2011 ; 101: 259-264
38. Papanas N, Lazarides MK.. Diabetic foot amputations in Greece: where do we go from here?. Int J Low Extrem Wounds. 2011 ; 10: 4-5
39. Papanas N, Maltezos E, Edmonds M.. Salvation of the diabetic foot: still a quest for the Holy Grail?. Vasa. 2011 ; 40: 267-269
40. Manu CA, Mustafa OG, Bates M, et al. Transformation of the multidisciplinary diabetic foot clinic into a multidisciplinary diabetic foot day unit: results from a service evaluation. Int J Low Extrem Wounds. 2014 ; 13: 173-179
41. Papanas N, Mani R.. How to cope with the increasing burden of the diabetic foot: better three hours too soon than a minute too late. Int J Low Extrem Wounds. 2014 ; 13: 171-172